President Mei Yanchang Personally Welcomes Zhongce Group Leadership Team to ANRim Hong Kong Laboratory for Inspection and Exchange
Recently, accompanied by Professor Mei Yanchang, President of City University of Hong Kong, the leaders of Zhongce Group led a team to visit ANRim Hong Kong Laboratory for research and exchange, and to gain an in-depth understanding of the company's innovative breakthroughs in the field of nanobiotechnology.
Recently, accompanied by Professor Mei Yanchang, President of City University of Hong Kong, the leaders of Zhongce Group led a team to visit ANRim Hong Kong Laboratory for research and exchange, and to gain an in-depth understanding of the company's innovative breakthroughs in the field of nanobiotechnology.
The leader of China Policy Group & the President of CITYU Mei listened to Professor Zhang Wenjun (middle) introduce the transformation of ANRim scientific research
Core technology display
The co-founder of Anrui Biology, the director of the Research Center for Super Diamond and Advanced Thin Films (COSDAF), and the Vice Dean of the School of Engineering, City University of Hong Kong, Professor Zhang Wenjun highlighted：
- Revolutionary nano-needle transfection technology-using original "seamless delivery” technology, gene editing efficiency is significantly improved
- A new generation of spatial transcriptomics platform-combining the advantages of nanotechnologies to achieve microenvironment analysis with subcellular precision
In-depth dialogue between industry, university and research
President Mei Yanchang said that Anrui Biological is a benchmark company cultivated by HK Tech 300, and its nanotechnological transformation achievements fully demonstrate the strength of CityU in promoting technological innovation. We look forward to working with China Policy Group to accelerate the industrialization of these breakthrough technologies.
Highly rated by Zhongce Group
The leaders of Zhongce Group pointed out that Anrui's innovative technologies have broad application prospects in the big health industry, especially in the fields of precision medicine and biopharmaceuticals. China Policy Group looks forward to in-depth cooperation with CityU Hong Kong and Anrui.
Prospects for future cooperation
- Jointly build the "China Policy-Urban University Biotechnology Transformation Fund”
- Joint development of new gene therapy solutions
- Cultivate more biotechnology talents through the HK Tech 300 platform
HK Tech 300
"HK Tech 300" is a large-scale innovation and entrepreneurship project organized by the City University of Hong Kong (CityU). With the theme of "Innovation and Technology Lead the Future Infinitely", it is committed to providing young people with diversified education and self-improvement opportunities, while transforming CityU's research results and intellectual property rights into practical applications. CityU HK Tech 300 allocated a total of HK港元600 million to create 300 start-ups within three years.
